Show simple item record

dc.contributor.authorYüksel, Mehmet Onur
dc.contributor.authorÇevik, Serdar
dc.contributor.authorErdoğan, Barış
dc.contributor.authorKatar, Salim
dc.contributor.authorTunçkale, Tamer
dc.contributor.authorÇalışkan, Tezcan
dc.contributor.authorErvan, Şevket
dc.date.accessioned2021-02-11T05:58:11Z
dc.date.available2021-02-11T05:58:11Z
dc.date.issued2020en_US
dc.identifier.citationYüksel, M. O., Çevik, S., Erdoğan, B., Katar, S., Tunçkale, T., Çalışkan, T. ... Ervan, Ş. (2020). The effectiveness of the amount of polymethylmethacrylate used in the treatment of lumbar osteoporotic compression fractures. Medical Journal of Bakırköy, 16(4), 330-335. https://dx.doi.org/10.5222/BMJ.2020.19483en_US
dc.identifier.issn1305-9319
dc.identifier.issn1305-9327
dc.identifier.urihttps://dx.doi.org/10.5222/BMJ.2020.19483
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6544
dc.description.abstractObjective: We aimed to investigate the effectiveness of the amount of polymethylmethacrylate used in pain control and maintenance of long-term vertebra corpus height in patients undergoing percutaneous vertebroplasty due to osteoporotic compression fracture of the lumbar vertebra.Method: A total of 60 patients who underwent unilateral percutaneous vertebroplasty between 2014 and 2019 due to osteoporotic compression fracture of the lumbar vertebrae were included in the study. Patients who received 5 ml and 3 ml cement injection were retrospectively analyzed. Of patients, postoperative visual analogue scale (VAS) score and anterior vertebral height of the patients at 1st-year control were evaluated.Results: In the postoperative period, the mean visual analogue scale score was 2.3 +/- 0.46 in the 5 ml injected group and 2.2 +/- 0.4 in the 3 ml injected group (p5 ml=0.001, p3 ml=0.001). There was a statistically significant decline in pain control in both groups. The mean anterior vertebral height loss (AVHL) in the 5 ml injected group was 31.5 +/- 0.40%, and 32.6 +/- 0.47% in the 3 ml injected group (p5 ml=0.820, p3ml=0.870). There was no statistically significant alteration in both groups.Conclusion: Our results indicate that the 3 ml polymethylmethacrylate injection during the percutaneous vertebroplasty procedure provides adequate pain control and stabilization in patients with lumbar vertebral osteoporotic fracture. Therefore we think that small amount of polymethylmethacrylate (3 ml) is sufficient to avoid undesirable complications in this patient group.en_US
dc.language.isoengen_US
dc.publisherYerküre Tanıtım ve Yayıncılık A.Ş.en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCompression Fracturesen_US
dc.subjectOsteoporotic Fracturesen_US
dc.subjectPainen_US
dc.subjectPolymethyl Methacrylateen_US
dc.subjectSpinal Fracturesen_US
dc.subjectVertebroplastyen_US
dc.subjectVisual Analog Scaleen_US
dc.titleThe effectiveness of the amount of polymethylmethacrylate used in the treatment of lumbar osteoporotic compression fracturesen_US
dc.typearticleen_US
dc.relation.journalMedical Journal of Bakırköyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Beyin ve Sinir Cerrahisi Ana Bilim Dalıen_US
dc.authorid0000-0003-0922-4249en_US
dc.identifier.volume16en_US
dc.identifier.issue4en_US
dc.identifier.startpage330en_US
dc.identifier.endpage335en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.5222/BMJ.2020.19483en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess